FDA Adverse Event Injury Summary report: N

UNSPECIFIED HA FILLER

MDR report key: 4666928 · Received March 24, 2015

Report

Report Number
1000118068-2015-00001
Event Type
Injury
Date Received
March 24, 2015
Report Date
February 24, 2015
Manufacturer
GALDERMA Q-MED
Product Code
LMH
PMA / PMN Number
P040024
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CORRECTED DATA: GALDERMA LABORATORIES L.P. (B)(4). PHARMACOVIGILANCE COMMENT: A CAUSAL RELATION BETWEEN THE EVENT AND THE TREATMENT CANNOT BE EXCLUDED. THE VASCULARISATION OF THE NOSE TIP MAY BE ALTERED BY A SURGICAL PROCEDURE. ISOLATED RARE CASES OF ISCHEMIA/NECROSIS AFFECTING THE NOSE FOLLOWING INJECTION TREATMENT IN PTS WHO HAD PRIOR RHINOPLASTY, HAVE BEEN REPORTED. THE REPORTED EVENT IS ADDRESSED IN THE LABEL. THIS LITERATURE ARTICLE DESCRIBES THAT THE PT WAS INJECTED WITH A HYALURONIC ACID FILLER. ALTHOUGH THE PRODUCT NAME IS NOT REPORTED, IT CANNOT BE EXCLUDED THAT A Q-MED PRODUCT IS INVOLVED.

Description of Event or Problem · 1

CASE REFERENCE NUMBER (B)(4) IS A LITERATURE REPORT BY A PHYSICIAN WHICH REFERS TO A FEMALE AGED (B)(6). AFTER FOUR RHINOPLASTIES, THIS (B)(6) WOMAN WAS INJECTED WITH A HYALURONIC ACID FILLER TO IMPROVE TIP PROJECTION. "THE TIP TURNED WHITE AND THEN BLACK" WITH NECROSIS. THE WOUND HEALED SECONDARILY. THE SKIN OF THE TIP AND DORSUM WAS SCARRED. THE TIP LACKED PROJECTION. HER BREATHING WAS SATISFACTORY. THIS PAPER ILLUSTRATED THE USE OF A 3 STAGE FOREHEAD FLAP AND ANATOMIC RECONSTRUCTION OF THE TIP CARTILAGES TO REPAIR A FULL THICKNESS NECROSIS OF THE TIP AFTER A COSMETIC FILLER INJECTION. AN OVERVIEW OF PRESENTATION AND TREATMENT OF THIS COMPLICATION IS PRESENTED WITH RECONSTRUCTIVE GUIDELINES TO DIRECT THE SURGEON TO SUCCESSFUL REPAIR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
197617 UNSPECIFIED HA FILLER IMPLANT, DERMAL, FOR AESTHETIC USE (LMH) LMH GALDERMA Q-MED UNK

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention